Revenue
2021
2022
2023
2024
2025
2026
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue | £1.92B | £1.93B | £1.91B | £1.58B | £1.32B | £1.28B |
| Research & development | — | — | — | −£17.4M | −£6.2M | — |
| Operating expenses | £1.73B | £1.78B | £1.74B | £1.43B | — | — |
| Operating income | £169.8M | −£90.5M | £192.5M | £172.8M | £123.7M | £108.7M |
| Operating margin | 8.83% | −4.69% | 10.07% | 10.93% | 9.37% | 8.50% |
| EBITDA | £296.3M | £26.2M | £292.9M | £279.2M | — | — |
| EBITDA margin | 15.41% | 1.36% | 15.32% | 17.66% | — | — |
| Net income | £107.5M | −£185.7M | £139.6M | £154.4M | £90.0M | £121.9M |
| Net profit margin | 5.59% | −9.61% | 7.30% | 9.77% | 6.82% | 9.54% |
| Basic EPSper basic share | £0.20 | -£0.33 | £0.24 | £0.27 | £0.16 | £0.21 |
| Diluted EPSper diluted share | £0.20 | -£0.33 | £0.24 | £0.27 | £0.16 | £0.21 |